Centene Corporation Reports 2016 Fourth Quarter And Full Year Results
-- 2016 Full Year Diluted EPS of $3.41; Adjusted Diluted EPS of $4.43 --

ST. LOUIS, Feb. 7, 2017 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today its financial results for the fourth quarter and year ended December 31, 2016.  The following discussions, with the exception of cash flow information, are in the context of continuing operations.

For the fourth quarter and year ended December 31, 2016, the Company reported diluted earnings per share (EPS) of $1.45 and $3.41, respectively, and Adjusted Diluted EPS of $1.19 and $4.43, respectively.  A summary of diluted EPS is highlighted below:

 

Q4

 

Full Year

GAAP diluted EPS

$

1.45

   

$

3.41

 

Health Net acquisition related expenses

0.03

   

0.98

 

Amortization of acquired intangible assets

0.20

   

0.57

 

California minimum medical loss ratio change (1)

(0.71)

   

(0.76)

 

Charitable contribution (2)

0.18

   

0.19

 

Debt extinguishment (3)

0.04

   

0.04

 

   Adjusted Diluted EPS

$

1.19

   

$

4.43

 
   

(1)

A favorable impact associated with the retroactive change in the minimum medical loss ratio (MLR) calculation under California's Medicaid expansion program, $195 million of which relates to periods prior to 2016 for the legacy Centene business and prior to the acquisition date for the legacy Health Net business. 

   

(2)

In connection with the additional revenue associated with the California minimum MLR change, the Company committed to a charitable contribution to its foundation of $50 million in the fourth quarter of 2016. 

   

(3)

Additional expense of $11 million associated with the early redemption of the 5.75% Senior Notes due 2017 and the Health Net Inc. 6.375% Senior Notes due 2017. 

 

Included in diluted EPS and Adjusted Diluted EPS for the fourth quarter and year ended December 31, 2016 are $0.03 and $0.05 diluted EPS benefits, respectively, related to the early adoption of the stock-based compensation accounting standard, as well as the incorporation of retirement provisions in our stock-based compensation agreements.

In summary, the 2016 fourth quarter and full year results were as follows:

2016 Results

 

Q4

 

Full Year

Total revenues (in millions)

$

11,911

   

$

40,607

 

Health benefits ratio

84.8

%

 

86.5

%

Selling, general & administrative expense ratio

10.0

%

 

9.8

%

Selling, general & administrative expense ratio, excluding Health Net acquisition related expenses

9.9

%

 

9.2

%

GAAP diluted EPS

$

1.45

   

$

3.41

 

Adjusted Diluted EPS

$

1.19

   

$

4.43

 

Total cash flow provided by operations (in millions)

$

1,596

   

$

1,851

 

 

Michael F. Neidorff, Centene's Chairman and Chief Executive Officer, stated, "Our strong fourth quarter results give us favorable operating momentum heading into 2017, and the successful integration of Health Net bolsters this with greater scale and product diversity."

Fourth Quarter and Full Year Highlights

  • December 31, 2016 managed care membership of 11.4 million, an increase of 6.3 million members, or 124% over 2015.
  • Total revenues for the fourth quarter of 2016 of $11.9 billion, representing 89% growth compared to the fourth quarter of 2015 and $40.6 billion for the full year 2016, representing 78% growth year over year.
  • Health benefits ratio (HBR) of 84.8% for the fourth quarter of 2016 compared to 88.0% in the fourth quarter of 2015 and 86.5% for the full year 2016 compared to 88.9% for the full year 2015.
  • Selling, general and administrative (SG&A) expense ratio of 10.0% for the fourth quarter of 2016 compared to 8.7% for the fourth quarter of 2015. SG&A expense ratio of 9.8% for the full year 2016 compared to 8.5% for the full year 2015.
  • SG&A expense ratio excluding Health Net acquisition related expenses of 9.9% for the fourth quarter of 2016 compared to 8.6% for the fourth quarter of 2015. SG&A expense ratio excluding Health Net acquisition related expenses of 9.2% for the full year 2016 compared to 8.3% for the full year 2015.
  • Operating cash flow of $1.6 billion and $1.9 billion for the fourth quarter and full year of 2016, respectively, representing 3.3x net earnings for the full year of 2016.
  • Diluted EPS for the fourth quarter of 2016 of $1.45 compared to $0.91 for the fourth quarter of 2015. Diluted EPS for the full year of 2016 of $3.41 compared to $2.89 for the full year of 2015.
  • Adjusted Diluted EPS for the fourth quarter of 2016 of $1.19 compared to $0.97 for the fourth quarter of 2015. Adjusted Diluted EPS for the full year of 2016 of $4.43 compared to $3.14 for the full year of 2015.

Other Events

  • In January 2017, we signed a joint venture agreement with the North Carolina Medical Society, working in conjunction with the North Carolina Community Health Center, to collaborate on a patient-focused approach to Medicaid under the reform plan enacted in the State of North Carolina. The newly created health plan, Carolina Complete Health, was created to establish, organize and operate a physician-led health plan to provide Medicaid managed care services in North Carolina.
  • In January 2017, our Pennsylvania subsidiary, Pennsylvania Health & Wellness, was selected by the Pennsylvania Department of Human Services to serve Medicaid recipients enrolled in the HealthChoices program in three zones. Pending regulatory approval and successful completion of a readiness review, the three-year agreement is expected to commence June 1, 2017.
  • In January 2017, our Indiana subsidiary, Managed Health Services, began operating under a contract with the Indiana Family & Social Services Administration to provide risk-based managed care services for enrollees in the Healthy Indiana Plan and Hoosier Healthwise programs.
  • In January 2017, our Nebraska subsidiary, Nebraska Total Care, began operating under a contract with the Nebraska Department of Health and Human Services' Division of Medicaid and Long Term Care as one of three managed care organizations to administer its new Heritage Health Program for Medicaid, ABD, CHIP, Foster Care and LTC enrollees.
  • In November 2016, our subsidiary, Peach State Health Plan, was awarded a statewide managed care contract to continue serving members enrolled in the Georgia Families managed care program, including PeachCare for Kids and Planning for Healthy Babies. Through the new contract, Peach State Health Plan will be one of four managed care organizations providing medical, behavioral, dental and vision health benefits for its members. The contract is expected to become effective July 1, 2017.
  • In November 2016, our Nevada subsidiary, Silver Summit Health Plan, was selected to serve Medicaid recipients enrolled in Nevada's Medicaid managed care program. The contract is expected to commence on July 1, 2017, pending regulatory approval and successful completion of a readiness review.
  • In November 2016, the Company issued $1.2 billion in aggregate principal amount of 4.75% Senior Notes due 2025. The Company used the net proceeds of the offering to redeem its 5.75% Senior Notes due 2017 and Health Net Inc.'s 6.375% Senior Notes due 2017, to repay amounts outstanding under its Revolving Credit Facility, to pay related fees and expenses and for general corporate purposes.

Membership

The following table sets forth the Company's membership by state for its managed care organizations:

 

December 31,

 

2016

 

2015

Arizona

598,300

 

440,900

Arkansas

58,600

 

41,900

California

2,973,500

 

186,000

Florida

716,100

 

510,400

Georgia

488,000

 

408,600

Illinois

237,700

 

207,500

Indiana

285,800

 

282,100

Kansas

139,700

 

141,000

Louisiana

472,800

 

381,900

Massachusetts

48,300

 

61,500

Michigan

2,000

 

4,800

Minnesota

9,400

 

9,600

Mississippi

310,200

 

302,200

Missouri

105,700

 

95,100

New Hampshire

77,400

 

71,400

New Mexico

7,100

 

Ohio

316,000

 

302,700

Oregon

217,800

 

98,700

South Carolina

122,500

 

104,000

Tennessee

21,700

 

20,000

Texas

1,072,400

 

983,100

Vermont

1,600

 

1,700

Washington

238,400

 

209,400

Wisconsin

73,800

 

77,100

Total at-risk membership

8,594,800

 

4,941,600

TRICARE eligibles

2,847,000

 

Non-risk membership

 

166,300

Total

11,441,800

 

5,107,900

 

The following table sets forth our membership by line of business:

 

December 31,

 

2016

 

2015

Medicaid:

     

TANF, CHIP & Foster Care

5,630,000

 

3,763,400

ABD & LTC

785,400

 

478,600

Behavioral Health

466,600

 

456,800

Commercial

1,239,100

 

146,100

Medicare & Duals (1)

334,300

 

37,400

Correctional

139,400

 

59,300

   Total at-risk membership

8,594,800

 

4,941,600

TRICARE eligibles

2,847,000

 

Non-risk membership

 

166,300

   Total

11,441,800

 

5,107,900

 

(1) Membership includes Medicare Advantage, Medicare Supplement, Special Needs Plans, and Medicare-Medicaid Plans.

 

At December 31, 2016, the Company served 1,080,500 members in Medicaid expansion programs in ten states, compared to 449,000 members in eight states at December 31, 2015.  At December 31, 2016, the Company served 372,800 dual-eligible members, compared to 204,800 at December 31, 2015.  At December 31, 2016, the Company served 537,200 members in Health Insurance Marketplaces, compared to 146,100 at December 31, 2015.

Statement of Operations: Three Months Ended December 31, 2016

  • For the fourth quarter of 2016, total revenues increased 89% to $11.9 billion from $6.3 billion in the comparable period in 2015. The increase over prior year was primarily a result of the acquisition of Health Net, the impact from expansions and new programs in many of our states in 2015 and 2016, and growth in the Health Insurance Marketplace business in 2016. Sequentially, revenue increased over the third quarter of 2016 partially due to $195 million of revenue recognized associated with the minimum MLR change in California. Additionally, during the fourth quarter we received approximately $500 million associated with pass through payments from the state of California that were recorded in Premium tax revenue and Premium tax expense.
  • HBR of 84.8% for the fourth quarter of 2016 represents a decrease from 88.0% in the comparable period in 2015 and a decrease from 87.0% in the third quarter of 2016. The year over year HBR decrease is primarily attributable to the acquisition of Health Net, which operates at a lower HBR due to a higher mix of commercial business. Also, in the fourth quarter of 2016, we recognized revenue relating to amendments to our California contracts with the Department of Health Care Services to amend the Medicaid expansion minimum MLR definition, reducing the fourth quarter HBR by 170 basis points.
  • SG&A expense ratio of 10.0% for the fourth quarter of 2016 compared to 8.7% for the fourth quarter of 2015. SG&A expense ratio excluding Health Net acquisition related expenses of 9.9% for the fourth quarter of 2016 compared to 8.6% for the fourth quarter of 2015. The increase in the SG&A expense ratio is primarily attributable to the addition of the Health Net business, which operates at a higher SG&A expense ratio due to a higher mix of commercial and Medicare business. The charitable contribution of $50 million increased the fourth quarter SG&A expense ratio by 50 basis points.

Statement of Operations: Year Ended December 31, 2016

  • Total revenues increased 78% in the year ended December 31, 2016 over the corresponding period in 2015 primarily as a result of the acquisition of Health Net, growth in the Health Insurance Marketplace business, and the impact from expansions, acquisitions or new programs in many of our states in 2016 and 2015.
  • The consolidated HBR for the year ended December 31, 2016 was 86.5%, a decrease of 240 basis points over the comparable period in 2015. The decrease compared to last year is primarily attributable to the acquisition of Health Net, membership growth in Medicaid expansion and Health Insurance Marketplace products, and improvement in HBR in the higher acuity populations. Also, in the fourth quarter we recognized additional revenue relating to the California minimum MLR change, which reduced our 2016 HBR by 50 basis points.
  • SG&A expense ratio of 9.8% for the full year 2016 compared to 8.5% for the full year 2015. SG&A expense ratio excluding Health Net acquisition related expenses of 9.2% for the full year 2016 compared to 8.3% for the full year 2015. The increase in the SG&A expense ratio is primarily attributable to the addition of the Health Net business.

Balance Sheet and Cash Flow

At December 31, 2016, the Company had cash, investments and restricted deposits of $9.1 billion, including $264 million held by its unregulated entities.  Medical claims liabilities totaled $3.9 billion.  The Company's days in claims payable was 42.  Total debt was $4.7 billion, which includes $100 million of borrowings on the $1 billion revolving credit facility at quarter-end.  The debt to capitalization ratio was 43.7% at December 31, 2016, excluding the $64 million non-recourse mortgage note.

Cash flow provided by operations for the three months ended December 31, 2016, was $1.6 billion. The cash provided by operating activities during the quarter reflects a decrease in premium and related receivables and an increase in accounts payable and accrued expenses.  The fourth quarter 2016 cash provided by operations was increased by approximately $445 million due to the finalization of the opening balance sheet for Health Net. 

A reconciliation of the Company's change in days in claims payable from the immediately preceding quarter-end is presented below:

     

Days in claims payable, September 30, 2016

41

 

Timing of claims payments

1

 

Days in claims payable, December 31, 2016

42

 
     

 

Outlook

The table below depicts the Company's annual guidance for 2017 and reflects a revised GAAP diluted EPS range to reflect the updated amortization expense as a result of finalizing the Health Net opening balance sheet intangibles valuation in the fourth quarter of 2016.

   

Full Year 2017

 
   

Low

 

High

 

Total revenues (in billions)

 

$

46.0

   

$

46.8

   

GAAP diluted EPS

 

$

3.82

   

$

4.26

   

Adjusted Diluted EPS (1)

 

$

4.40

   

$

4.85

   

HBR

 

87.0

%

 

87.5

%

 

SG&A expense ratio

 

9.0

%

 

9.5

%

 

SG&A expense ratio, excluding Health Net acquisition related expenses

 

9.0

%

 

9.5

%

 

Effective tax rate

 

39.0

%

 

41.0

%

 

Diluted shares outstanding (in millions)

 

176.9

   

177.9

   
           
   

(1)

Adjusted Diluted EPS excludes Health Net acquisition related expenses of $0.01 to $0.03 per diluted share and amortization of acquired intangible assets of $0.54 to $0.58 per diluted share.

 

Conference Call

As previously announced, the Company will host a conference call Tuesday, February 7, 2017, at 8:30 AM (Eastern Time) to review the financial results for the fourth quarter and year ended December 31, 2016, and to discuss its business outlook.  Michael Neidorff and Jeffrey Schwaneke will host the conference call. 

Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 4994074 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com , under the Investors section.

A webcast replay will be available for on-demand listening shortly after the completion of the call for the next twelve months or until 11:59 PM (Eastern Time) on Tuesday, February 6, 2018, at the aforementioned URL. In addition, a digital audio playback will be available until 9:00 AM (Eastern Time) on Tuesday, February 14, 2017, by dialing 1-877-344-7529 in the U.S. and Canada, or +1-412-317-0088 from abroad, and entering access code 10098783.

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures in this release as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently across periods. The Company uses the presented non-GAAP financial measures internally to allow management to focus on period-to-period changes in the Company's core business operations. Therefore, the Company believes that this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

Specifically, the Company believes the presentation of non-GAAP financial information that excludes Health Net acquisition related expenses, amortization of acquired intangible assets, as well as other items, allows investors to develop a more meaningful understanding of the Company's performance over time. The tables below provide reconciliations of non-GAAP items ($ in millions, except per share data): 

 

Three Months
Ended

December 31,

 

Year Ended
December 31,

 

2016

 

2015

 

2016

 

2015

GAAP net earnings from continuing operations

$

255

 

$

112

 

$

559

 

$

356

Health Net acquisition related expenses

10

 

7

 

234

 

27

Amortization of acquired intangible assets

52

 

6

 

147

 

24

California minimum MLR change (1)

(195)

 

 

(195)

 

Charitable contribution (2)

50

 

 

50

 

Debt extinguishment (3)

11

 

 

11

 

Income tax effects of adjustments (4)

27

 

(5)

 

(79)

 

(20)

Adjusted net earnings from continuing operations

$

210

 

$

120

 

$

727

 

$

387

   

(1)

 A favorable impact associated with the retroactive change in the minimum MLR calculation under California's Medicaid expansion program, $195 million of which relates to periods prior to 2016 for the legacy Centene business and prior to the acquisition date for the legacy Health Net business. 

   

(2)

 In connection with the additional revenue associated with the California minimum MLR change, the Company committed to a charitable contribution to its foundation of $50 million in the fourth quarter of 2016. 

   

(3)

Additional expense of $11 million associated with the early redemption of the 5.75% Senior Notes due 2017 and the Health Net Inc. 6.375% Senior Notes due 2017. 

   

(4)

The income tax effects of adjustments are based on the effective income tax rates applicable to adjusted (non-GAAP) results. The amounts are based on the effective income tax rate that would increase or decrease based on the exclusion of these exceptions.

 

 

Three Months
Ended

December 31,

 

Year Ended
December 31,

 

Annual
Guidance
December 31,

 

2016

 

2015

 

2016

 

2015

 

2017

GAAP diluted earnings per share (EPS)

$

1.45

 

 

$

0.91

 

 

$

3.41

 

 

$

2.89

 

 

$3.82 - $4.26

Health Net acquisition related expenses (1)

0.03

 

 

0.03

 

 

0.98

 

 

0.14

 

 

$0.01 - $0.03

Amortization of acquired intangible assets (2)

0.20

 

 

0.03

 

 

0.57

 

 

0.11

 

 

$0.54 - $0.58

California minimum MLR change (3)

(0.71)

 

 

 

 

(0.76)

 

 

 

 

Charitable contribution (4)

0.18

 

 

 

 

0.19

 

 

 

 

Debt extinguishment (5)

0.04

 

 

 

 

0.04

 

 

 

 

   Adjusted Diluted EPS

$

1.19

 

 

$

0.97

 

 

$

4.43

 

 

$

3.14

 

 

$4.40 - $4.85

   

(1)

The Health Net acquisition related expenses per diluted share presented above are net of the income tax benefit of $0.03 and $0.02 for the three months ended December 31, 2016 and 2015, respectively, and $0.45 and $0.08 for the years ended December 31, 2016 and 2015, respectively; and estimated $0.01 to $0.02 for the year ended December 31, 2017.

   

(2)

The amortization of acquired intangible assets per diluted share presented above are net of the income tax benefit of $0.10 and $0.02 for the three months ended December 31, 2016 and 2015, respectively, and $0.33 and $0.08 for the years ended December 31, 2016 and 2015, respectively; and estimated $0.31 to $0.35 for the year ended December 31, 2017.

   

(3)

The impact associated with the retroactive change in the minimum MLR calculation per diluted share presented above is net of income tax expense of $(0.40) for the quarter ended December 31, 2016 and $(0.43) and for the year ended December 31, 2016.

   

(4)

The charitable contributions per diluted share presented above are net of the income tax benefit of $0.10 for the quarter ended December 31, 2016 and $0.11 for the year ended December 31, 2016.

   

(5)

The debt extinguishment cost per diluted share presented above is net of income tax benefit of $0.02 for the quarter ended December 31, 2016 and $0.03 for the year ended December 31, 2016.

 

 

Three Months
Ended

December 31,

 

Year Ended

December 31,

 

2016

 

2015

 

2016

 

2015

GAAP SG&A expenses

$

1,065

 

$

511

 

$

3,676

 

$

1,802

Health Net acquisition related expenses

10

 

7

 

234

 

27

SG&A expenses, excluding Health Net acquisition related expenses

$

1,055

 

$

504

 

$

3,442

 

$

1,775

 

About Centene Corporation

Centene Corporation is a diversified, multi-national healthcare enterprise that provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and Long Term Care (LTC), in addition to other state-sponsored programs, Medicare (including the Medicare prescription drug benefit commonly known as "Part D"), dual eligible programs and programs with the U.S. Department of Defense and U.S. Department of Veterans Affairs. Centene also provides healthcare services to groups and individuals delivered through commercial health plans. Centene operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health management, care management software, correctional healthcare services, dental benefits management, in-home health services, life and health management, managed vision, pharmacy benefits management, specialty pharmacy and telehealth services.

Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, http://www.centene.com/investors.

Forward-Looking Statements

The company and its representatives may from time to time make written and oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act ("PSLRA") of 1995, including statements in this and other press releases, in presentations, filings with the Securities and Exchange Commission ("SEC"), reports to stockholders and in meetings with investors and analysts. In particular, the information provided in this press release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of Centene and certain plans and objectives of Centene with respect thereto, including but not limited to the expected benefits of the acquisition of Health Net, Inc. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Without limiting the foregoing, forward-looking statements often use words such as "anticipate", "seek", "target", "expect", "estimate", "intend", "plan", "goal", "believe", "hope", "aim", "continue", "will", "may", "can", "would", "could" or "should" or other words of similar meaning or the negative thereof. We intend such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in PSLRA.  A number of factors, variables or events could cause actual plans and results to differ materially from those expressed or implied in forward-looking statements. Such factors include, but are not limited to, Centene's ability to accurately predict and effectively manage health benefits and other operating expenses and reserves; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies and advances in medicine; increased health care costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to government health care programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act and any regulations enacted thereunder that may result from changing political conditions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting Centene's government businesses; Centene's ability to adequately price products on federally facilitated and state based Health Insurance Marketplaces; tax matters; disasters or major epidemics; the outcome of legal or regulatory proceedings; changes in expected contract start dates; provider, state, federal and other contract changes and timing of regulatory approval of contracts; the expiration, suspension or termination of Centene's contracts with federal or state governments (including but not limited to Medicaid, Medicare, and TRICARE); challenges to Centene's contract awards; cyber-attacks or other privacy or data security incidents; the possibility that the expected synergies and value creation from acquired businesses, including, without limitation, the Health Net acquisition, will not be realized, or will not be realized within the expected time period, including, but not limited to, as a result of conditions, terms, obligations or restrictions imposed by regulators in connection with their approval of, or consent to, the acquisition; the exertion of management's time and Centene's resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with certain regulatory approvals; disruption from the acquisition making it more difficult to maintain business and operational relationships; the risk that unexpected costs will be incurred in connection with, among other things, the acquisition and/or the integration; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully; Centene's ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and other quality scores that impact revenue; availability of debt and equity financing, on terms that are favorable to Centene; inflation; foreign currency fluctuations; and risks and uncertainties discussed in the reports that Centene has filed with the SEC. These forward-looking statements reflect Centene's current views with respect to future events and are based on numerous assumptions and assessments made by Centene in light of its experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors it believes appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future.  The factors described in the context of such forward-looking statements in this press release could cause Centene's plans with respect to the Health Net acquisition, actual results, performance or achievements, industry results and developments to differ materially from those expressed in or implied by such forward-looking statements. Although it is currently believed that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct and persons reading this press release are therefore cautioned not to place undue reliance on these forward-looking statements which speak only as of the date of this press release. Centene does not assume any obligation to update the information contained in this press release (whether as a result of new information, future events or otherwise), except as required by applicable law.  This list of important factors is not intended to be exhaustive. We discuss certain of these matters more fully, as well as certain other risk factors that may affect Centene's business operations, financial condition and results of operations, in Centene's filings with the SEC, including the annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

[Tables Follow]

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In millions, except share data)

(Unaudited)

 
 

December 31, 2016

 

December 31, 2015

ASSETS

     

Current assets:

     

Cash and cash equivalents

$

3,930

   

$

1,760

 

Premium and related receivables

3,098

   

1,279

 

Short term investments

505

   

176

 

Other current assets

832

   

390

 

   Total current assets

8,365

   

3,605

 

Long term investments

4,545

   

1,927

 

Restricted deposits

138

   

115

 

Property, software and equipment, net

797

   

518

 

Goodwill

4,712

   

842

 

Intangible assets, net

1,545

   

155

 

Other long term assets

95

   

177

 

   Total assets

$

20,197

   

$

7,339

 
       

LIABILITIES AND STOCKHOLDERS' EQUITY

     

Current liabilities:

     

Medical claims liability

$

3,929

   

$

2,298

 

Accounts payable and accrued expenses

3,763

   

976

 

Return of premium payable

614

   

207

 

Unearned revenue

313

   

143

 

Current portion of long term debt

4

   

5

 

   Total current liabilities

8,623

   

3,629

 

Long term debt

4,651

   

1,216

 

Other long term liabilities

869

   

170

 

   Total liabilities

14,143

   

5,015

 

Commitments and contingencies

     

Redeemable noncontrolling interests

145

   

156

 

Stockholders' equity:

     

Preferred stock, $0.001 par value; authorized 10,000,000 shares; no shares issued or outstanding at December 31, 2016 and December 31, 2015

   

 

Common stock, $.001 par value; authorized 400,000,000 shares; 178,134,306 issued and 171,919,071 outstanding at December 31, 2016, and 126,855,477 issued and 120,342,981 outstanding at December 31, 2015

   

 

Additional paid-in capital

4,190

   

956

 

Accumulated other comprehensive loss

(36)

   

(10)

 

Retained earnings

1,920

   

1,358

 

Treasury stock, at cost (6,215,235 and 6,512,496 shares, respectively)

(179)

   

(147)

 

   Total Centene stockholders' equity

5,895

   

2,157

 

Noncontrolling interest

14

   

11

 

      Total stockholders' equity

5,909

   

2,168

 

      Total liabilities and stockholders' equity

$

20,197

   

$

7,339

 

 

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(In millions, except share data)

(Unaudited)

 
 

Three Months Ended
December 31,

 

Year Ended
December 31,

 

2016

 

2015

 

2016

 

2015

Revenues:

             

Premium

$

10,100

   

$

5,415

   

$

35,399

   

$

19,389

 

Service

577

   

442

   

2,180

   

1,876

 

   Premium and service revenues

10,677

   

5,857

   

37,579

   

21,265

 

Premium tax and health insurer fee

1,234

   

445

   

3,028

   

1,495

 

   Total revenues

11,911

   

6,302

   

40,607

   

22,760

 

Expenses:

             

Medical costs

8,564

   

4,767

   

30,636

   

17,242

 

Cost of services

478

   

387

   

1,864

   

1,621

 

Selling, general and administrative expenses

1,065

   

511

   

3,676

   

1,802

 

Amortization of acquired intangible assets

52

   

6

   

147

   

24

 

Premium tax expense

1,103

   

357

   

2,563

   

1,151

 

Health insurer fee expense

128

   

54

   

461

   

215

 

   Total operating expenses

11,390

   

6,082

   

39,347

   

22,055

 

   Earnings from operations

521

   

220

   

1,260

   

705

 

Other income (expense):

             

Investment and other income

34

   

8

   

114

   

35

 

Interest expense

(75)

   

(11)

   

(217)

   

(43)

 

   Earnings from continuing operations, before income tax expense

480

   

217

   

1,157

   

697

 

Income tax expense

227

   

105

   

599

   

339

 

   Earnings from continuing operations, net of income tax expense

253

   

112

   

558

   

358

 

Discontinued operations, net of income tax expense (benefit) of $3, $0, $2, and $(1), respectively

6

   

(1)

   

3

   

(1)

 

   Net earnings

259

   

111

   

561

   

357

 

(Earnings) loss attributable to noncontrolling interests

2

   

   

1

   

(2)

 

   Net earnings attributable to Centene Corporation

$

261

   

$

111

   

$

562

   

$

355

 
               

Amounts attributable to Centene Corporation common shareholders:

Earnings from continuing operations, net of income tax expense

$

255

   

$

112

   

$

559

   

$

356

 

Discontinued operations, net of income tax expense (benefit)

6

   

(1)

   

3

   

(1)

 

   Net earnings

$

261

   

$

111

   

$

562

   

$

355

 
               

Net earnings (loss) per common share attributable to Centene Corporation:

Basic:

             

   Continuing operations

$

1.49

   

$

0.94

   

$

3.50

   

$

2.99

 

   Discontinued operations

0.04

   

(0.01)

   

0.02

   

(0.01)

 

      Basic earnings per common share

$

1.53

   

$

0.93

   

$

3.52

   

$

2.98

 
               

Diluted:

             

   Continuing operations

$

1.45

   

$

0.91

   

$

3.41

   

$

2.89

 

   Discontinued operations

0.04

   

(0.01)

   

0.02

   

(0.01)

 

      Diluted earnings per common share

$

1.49

   

$

0.90

   

$

3.43

   

$

2.88

 
               

Weighted average number of common shares outstanding:

       

Basic

171,143,624

 

119,486,183

 

159,567,607

 

119,100,744

Diluted

175,511,179

 

123,350,506

 

163,975,407

 

123,066,370

 

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions)

(Unaudited)

 
 

Year Ended December 31,

 

2016

 

2015

Cash flows from operating activities:

     

Net earnings

$

561

   

$

357

 

Adjustments to reconcile net earnings to net cash provided by operating activities

 

   Depreciation and amortization

278

   

111

 

   Stock compensation expense

148

   

71

 

   Debt extinguishment costs

(7)

   

 

   Deferred income taxes

92

   

(17)

 

   Gain on contingent consideration

(5)

   

(44)

 

   Goodwill and intangible adjustment

   

38

 

Changes in assets and liabilities

     

   Premium and related receivables

74

   

(360)

 

   Other assets

167

   

(102)

 

   Medical claims liabilities

145

   

536

 

   Unearned revenue

43

   

(27)

 

   Accounts payable and accrued expenses

402

   

39

 

   Other long term liabilities

(61)

   

51

 

   Other operating activities, net

14

   

5

 

      Net cash provided by operating activities

1,851

   

658

 

Cash flows from investing activities:

     

Capital expenditures

(306)

   

(150)

 

Purchases of investments

(2,450)

   

(1,321)

 

Sales and maturities of investments

1,656

   

669

 

Investments in acquisitions, net of cash acquired

(1,297)

   

(18)

 

Proceeds from asset sale

   

7

 

      Net cash used in investing activities

(2,397)

   

(813)

 

Cash flows from financing activities:

     

Proceeds from borrowings

8,946

   

1,925

 

Payment of long term debt

(6,076)

   

(1,583)

 

Common stock repurchases

(63)

   

(53)

 

Debt issuance costs

(76)

   

(4)

 

Other financing activities, net

(14)

   

20

 

      Net cash provided by financing activities

2,717

   

305

 

Effect of exchange rate changes on cash and cash equivalents

(1)

   

 

      Net increase in cash and cash equivalents

2,170

   

150

 

Cash and cash equivalents, beginning of period

1,760

   

1,610

 

Cash and cash equivalents, end of period

$

3,930

   

$

1,760

 

Supplemental disclosures of cash flow information:

     

Interest paid

$

165

   

$

55

 

Income taxes paid

$

556

   

$

328

 

Equity issued in connection with acquisitions

$

3,105

   

$

12

 

 

CENTENE CORPORATION

SUPPLEMENTAL FINANCIAL DATA FROM CONTINUING OPERATIONS

 
   

Q4

 

Q3

 

Q2

 

Q1

 

Q4

 
   

2016

 

2016

 

2016

 

2016

 

2015

 

MANAGED CARE MEMBERSHIP BY STATE

 

Arizona

 

598,300

   

601,500

   

597,700

   

607,000

   

440,900

   

Arkansas

 

58,600

   

57,700

   

52,800

   

50,700

   

41,900

   

California

 

2,973,500

   

3,004,500

   

3,097,600

   

3,125,400

   

186,000

   

Florida

 

716,100

   

732,700

   

726,200

   

660,800

   

510,400

   

Georgia

 

488,000

   

498,000

   

493,300

   

495,500

   

408,600

   

Illinois

 

237,700

   

236,700

   

234,700

   

239,100

   

207,500

   

Indiana

 

285,800

   

289,600

   

291,000

   

290,300

   

282,100

   

Kansas

 

139,700

   

145,100

   

144,800

   

141,100

   

141,000

   

Louisiana

 

472,800

   

455,600

   

375,300

   

381,200

   

381,900

   

Massachusetts

 

48,300

   

45,300

   

47,100

   

52,400

   

61,500

   

Michigan

 

2,000

   

2,100

   

2,200

   

2,600

   

4,800

   

Minnesota

 

9,400

   

9,400

   

9,500

   

9,500

   

9,600

   

Mississippi

 

310,200

   

313,900

   

323,800

   

328,300

   

302,200

   

Missouri

 

105,700

   

104,700

   

102,900

   

100,000

   

95,100

   

New Hampshire

 

77,400

   

78,400

   

79,700

   

81,500

   

71,400

   

New Mexico

 

7,100

   

7,100

   

7,100

   

   

   

Ohio

 

316,000

   

319,500

   

319,000

   

314,000

   

302,700

   

Oregon

 

217,800

   

218,400

   

221,500

   

209,000

   

98,700

   

South Carolina

 

122,500

   

119,700

   

113,700

   

107,700

   

104,000

   

Tennessee

 

21,700

   

21,600

   

20,800

   

20,100

   

20,000

   

Texas

 

1,072,400

   

1,041,600

   

1,037,000

   

1,036,700

   

983,100

   

Vermont

 

1,600

   

1,700

   

1,600

   

1,500

   

1,700

   

Washington

 

238,400

   

240,500

   

239,700

   

226,500

   

209,400

   

Wisconsin

 

73,800

   

75,100

   

76,100

   

78,400

   

77,100

   

      Total at-risk membership

 

8,594,800

   

8,620,400

   

8,615,100

   

8,559,300

   

4,941,600

   

TRICARE eligibles

 

2,847,000

   

2,815,700

   

2,815,700

   

2,819,700

   

   

Non-risk membership

 

   

   

   

161,400

   

166,300

   

   Total

 

11,441,800

   

11,436,100

   

11,430,800

   

11,540,400

   

5,107,900

   
                       
 

Medicaid:

                     

   TANF, CHIP & Foster Care

 

5,630,000

   

5,583,900

   

5,541,200

   

5,464,200

   

3,763,400

   

   ABD & LTC

 

785,400

   

754,900

   

757,500

   

757,600

   

478,600

   

   Behavioral Health

 

466,600

   

465,300

   

455,800

   

456,500

   

456,800

   

Commercial

 

1,239,100

   

1,333,000

   

1,391,500

   

1,487,900

   

146,100

   

Medicare & Duals (1)

 

334,300

   

333,500

   

332,600

   

334,100

   

37,400

   

Correctional

 

139,400

   

149,800

   

136,500

   

59,000

   

59,300

   

   Total at-risk membership

 

8,594,800

   

8,620,400

   

8,615,100

   

8,559,300

   

4,941,600

   

TRICARE eligibles

 

2,847,000

   

2,815,700

   

2,815,700

   

2,819,700

   

   

Non-risk membership

 

   

   

   

161,400

   

166,300

   

   Total

 

11,441,800

   

11,436,100

   

11,430,800

   

11,540,400

   

5,107,900

   
                       

(1) Membership includes Medicare Advantage, Medicare Supplement, Special Needs Plans, and Medicare-Medicaid Plans.

 
                       

NUMBER OF EMPLOYEES

 

30,500

   

29,400

   

28,900

   

28,000

   

18,200

   

 

 

Q4

 

Q3

 

Q2

 

Q1

 

Q4

 
 

2016

 

2016

 

2016

 

2016

 

2015

 
                     

DAYS IN CLAIMS PAYABLE  (a)

42

   

41

   

43

   

66

   

44

   

(a) Days in claims payable is a calculation of medical claims liabilities at the end of the period divided by average claims expense per calendar day for such period.  On a pro-forma basis, DCP for Q1 2016 was 42, reflecting adjusted medical costs to include a full quarter of Health Net operations.

                     

CASH, INVESTMENTS AND RESTRICTED DEPOSITS (in millions)

Regulated

$

8,854

   

$

7,825

   

$

7,324

   

$

7,682

   

$

3,900

   

Unregulated

264

   

268

   

196

   

139

   

78

   

   Total

$

9,118

   

$

8,093

   

$

7,520

   

$

7,821

   

$

3,978

   
                     

DEBT TO CAPITALIZATION

44.1

%

 

44.5

%

 

44.8

%

 

44.6

%

 

36.0

%

 

DEBT TO CAPITALIZATION EXCLUDING NON-RECOURSE DEBT (b)

43.7

%

 

44.1

%

 

44.4

%

 

44.3

%

 

34.7

%

 

(b) The non-recourse debt represents the Company's mortgage note payable ($64 million at December 31, 2016).

Debt to capitalization is calculated as follows: total debt divided by (total debt + total equity).

 

OPERATING RATIOS

 
 

Three Months Ended
December 31,

 

Year Ended
December 31,

 

2016

 

2015

 

2016

 

2015

HBR

84.8

%

 

88.0

%

 

86.5

%

 

88.9

%

SG&A expense ratio

10.0

%

 

8.7

%

 

9.8

%

 

8.5

%

SG&A expense ratio, excluding Health Net acquisition related expenses

9.9

%

 

8.6

%

 

9.2

%

 

8.3

%

 

MEDICAL CLAIMS LIABILITY

 

The changes in medical claims liability are summarized as follows (in millions):

 

Balance, December 31, 2015

 

$

2,298

 

Acquisitions

 

1,482

 

Incurred related to:

   

   Current period

 

30,946

 

   Prior period

 

(310)

 

      Total incurred

 

30,636

 

Paid related to:

   

   Current period

 

28,532

 

   Prior period

 

1,960

 

      Total paid

 

30,492

 

Balance, December 31, 2016, net

 

3,924

 

Reinsurance recoverable

 

5

 

Balance, December 31, 2016

 

$

3,929

 

 

Centene's claims reserving process utilizes a consistent actuarial methodology to estimate Centene's ultimate liability.  Any reduction in the "Incurred related to: Prior period" amount may be offset as Centene actuarially determines "Incurred related to: Current period."  As such, only in the absence of a consistent reserving methodology would favorable development of prior period claims liability estimates reduce medical costs.  Centene believes it has consistently applied its claims reserving methodology.  Additionally, as a result of minimum HBR and other return of premium programs, approximately $39 million of the "Incurred related to: Prior period" was recorded as a reduction to premium revenues.

The amount of the "Incurred related to: Prior period" above represents favorable development and includes the effects of reserving under moderately adverse conditions, new markets where we use a conservative approach in setting reserves during the initial periods of operations, receipts from other third party payors related to coordination of benefits and lower medical utilization and cost trends for dates of service December 31, 2015, and prior.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/centene-corporation-reports-2016-fourth-quarter-and-full-year-results-300403104.html

SOURCE Centene Corporation